Form SC 13G/A HOOKIPA Pharma Inc. Filed by: EcoR1 Capital, LLC
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
- AMD shares fall amid AI chip sector selloff
- JetBlue shares fall amid American results, fuel cost concerns
- Bloom Energy Corp. (BE) Tops Q3 EPS by 25c, Beats on Revenue; Offers FY26 Guidance
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- LKQ posts Q3 loss, replaces CEO amid Europe struggles
HOOKIPA Pharma Inc. (HOOK) PT Lowered to $48 at RBC Capital
November 15, 2024 6:32 AM ESTRBC Capital analyst Brian Abrahams lowered the price target on HOOKIPA Pharma Inc. (NASDAQ: HOOK) to $48.00 (from $50.00) while maintaining a Outperform rating.
The analyst comments "With enrollment wrapped up in the ph.II portion of the ongoing OL study... More



